PriceTargets.com logo

Akerna - KERN Stock Price Target and Predictions

  • Consensus Rating: N/A
  • Consensus Price Target: $0.00
  • Forecasted Upside: NaN
  • Number of Analysts: 0
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
$0.00 As of 02/9/2024 12:59 AM ET
+0 (0.00%)
Get New Akerna Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for KERN and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for KERN

Analyst Price Target is $0.00
This price target is based on 0 analysts offering 12 month price targets for Akerna in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a NaN upside from the last price of $0.00.

This chart shows the closing price for KERN for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is N/A

The current consensus among 0 polled investment analysts is to n/a stock in Akerna. This N/A consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
11/3/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
2/1/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
5/2/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
7/31/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
10/29/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
1/27/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
3/27/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
4/26/2024

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
3/24/2023HC WainwrightLower TargetNeutral$20.00Low
2/3/2023HC WainwrightLower TargetNeutral$30.00 ➝ $20.00Low
8/25/2022HC WainwrightDowngradeBuy ➝ NeutralLow
5/11/2022Alliance Global PartnersDowngradeBuy ➝ NeutralHigh
5/11/2022HC WainwrightLower Target$50.00 ➝ $30.00High
3/22/2022Lake Street CapitalDowngradeBuy ➝ HoldHigh
3/22/2022Alliance Global PartnersLower Target$100.00 ➝ $50.00High
2/25/2022HC WainwrightLower TargetBuy$100.00 ➝ $50.00Medium
11/22/2021OppenheimerInitiated CoverageOutperform$120.00Medium
11/10/2021HC WainwrightLower TargetIn-Line ➝ Buy$140.00 ➝ $100.00High
11/9/2021Alliance Global PartnersLower TargetBuy$170.00 ➝ $150.00Medium
7/23/2021Lake Street CapitalInitiated CoverageBuy$160.00High
7/19/2021HC WainwrightInitiated CoverageBuy$140.00Medium
2/5/2021Alliance Global PartnersBoost TargetBuy$160.00 ➝ $210.00High
11/12/2020Alliance Global PartnersLower TargetBuy$200.00 ➝ $160.00Low
12/19/2019Alliance Global PartnersInitiated CoverageBuy$360.00Medium
(Data available from 4/26/2019 forward)

News Sentiment Rating

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
9/29/2023
  • 1 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
10/29/2023
  • 1 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
11/28/2023
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
12/28/2023
  • 1 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
1/27/2024
  • 0 very positive mentions
  • 5 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
2/26/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
3/27/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
4/26/2024

Current Sentiment

  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

  • No positive mentions tracked during this time.

Very Positive

  • No very positive mentions tracked during this time.
Akerna logo
Akerna Corp. provides enterprise software solutions that enable regulatory compliance and inventory management in the United States and Canada. The company offers MJ Platform for the cannabis, hemp, and CBD industry; and Leaf Data Systems, a government regulatory software. It also provides consulting services to cannabis industry; business intelligence, data analytics and other software related services; and Last Call Analytics, a retail analytics platform. In addition, the company operates Solo, a seed-to-sale tagging and tracking software platform, and Trellis, a cultivation and compliance software platform. Akerna Corp. was founded in 2010 and is headquartered in Denver, Colorado.
Read More

Today's Range

Now: N/A

50 Day Range

MA: $5.89
Low: $0.31
High: $9.80

52 Week Range

Now: N/A

Volume

70,795 shs

Average Volume

339,022 shs

Market Capitalization

$64.92 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

3.02

Frequently Asked Questions

What sell-side analysts currently cover shares of Akerna?

The following Wall Street sell-side analysts have issued research reports on Akerna in the last year:
View the latest analyst ratings for KERN.

What is the current price target for Akerna?

0 Wall Street analysts have set twelve-month price targets for Akerna in the last year. has the lowest price target set, forecasting a price of $10,000,000.00 for Akerna in the next year.
View the latest price targets for KERN.

What is the current consensus analyst rating for Akerna?

Akerna currently has from Wall Street analysts. The stock has a consensus analyst rating of "N/A."
View the latest ratings for KERN.

What other companies compete with Akerna?

Other companies that are similar to Akerna include Ikena Oncology, MediciNova, Rallybio, Pro-Dex and Entera Bio. Learn More about companies similar to Akerna.

How do I contact Akerna's investor relations team?

Akerna's physical mailing address is 1601 ARAPAHOE STREET, DENVER CO, 80202. The company's listed phone number is 888-932-6537 and its investor relations email address is [email protected]. The official website for Akerna is www.akerna.com. Learn More about contacing Akerna investor relations.